We did not observe off-target toxicities in α-LGR5-ADC-treated mice; however, α-LGR5 does not cross-react with murine Lgr5, and it will be important to evaluate on-target, off-tumour toxicities in an appropriate model. The gene discussed is LGR5; the disease is neoplasm.